The Effect of Forkhead Box Class O1, Mammalian Target of Rapamycin Complex 1, Survivin, and Interleukin-17 on the Degree of Acne Vulgaris Based on Serum Levels
Keywords:Forkhead box Class O1, Mammalian target of rapamycin complex 1, Survivin, interleukin-17, Severity of acne vulgaris
BACKGROUND: Acne vulgaris (AV) is a health problem that is routinely found throughout the world and has an impact on the quality of life of sufferers. Several studies have shown that forkhead box Class O1 (FoxO1), the mammalian target of rapamycin complex 1 (mTORC1), survivin, and interleukin-17 (IL-17) play a role in the pathogenesis of multifactorial AV.
AIM: The study aims to determine the relationship between serum levels of FoxO1, mTORC1, survivin, and IL-17 with the severity of AV.
METHODS: This is observational research with cross-sectional design. Samples from venous blood sufferers of AV mild, moderate, and severe, each of 20 people were colected. Classification of AV was based on the criteria of Lehmann et al. Examination of serum levels of FoxO1, mTORC1, survivin, and IL-17 using the ELISA technique was done. The statistical test used was the ANOVA test and the Kruskal–Wallis test.
RESULTS: The results showed that average levels of FoxO1 decreased with increasing degree of severity of AV. An average increase in mTORC1, survivin, IL-17 levels with an increase in the severity of AV was found. Statistical test results showed a significant correlation of FoxO1, mTORC1, survivin levels, and the severity of AV (p < 0.05). IL-17 levels were not related to the severity of AV (p > 0.05).
CONCLUSION: This study concluded that FoxO1 levels decrease at increasing severity. Conversely, levels of mTORC1, survivin, and IL-17 increase with increasing degrees of the severity of AV.
Plum Analytics Artifact Widget Block
Karimkhani C, Dellavalle RP, Coffeng LE, Flohr C, Hay RJ, Langan SM, et al. Global skin disease morbidity and mortality: An update from the global burden of disease study 2013. JAMA Dermatol. 2017;153(5):406-12. https://doi.org/10.1001/ jamadermatol.2016.5538 PMid:28249066
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1211- 59. https://doi.org/10.3410/f.731220250.793569875 PMid:28919117
Smith RN, Mann NJ, Braue A, Mäkeläinen H, Varigos GA. The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: A randomized, investigator-masked, controlled trial. J Am Acad Dermatol. 2007;57(2):247- 56. https://doi.org/10.1016/j.jaad.2007.01.046 PMid:17448569
Mirdamadi Y, Thielitz A, Wiede A, Goihl A, Papakonstantinou E, Hartig R, et al. Insulin and insulin-like growth factor-1 can modulate the phosphoinositide-3-kinase/Akt/FoxO1 pathway in SZ95 sebocytes in vitro. Mol Cell Endocrinol. 2015;415:32-44. https://doi.org/10.1016/j.mce.2015.08.001 PMid:26257240
Melnik BC. FoxO1 - the key for the pathogenesis and therapy of acne? J Dtsch Dermatol Ges. 2010;8(2):105-14. https://doi. org/10.1111/j.1610-0387.2010.07344.x PMid:20151947
Melnik BC. Acne vulgaris: An inflammasomopathy of the sebaceous follicle induced by deviated FoxO1/mTORC1 signalling. Br J Dermatol. 2016;174(6):1186-8. https://doi. org/10.1111/bjd.14564 PMid:27317281
Agamia NF, Abdallah DM, Sorour O, Mourad B, Younan DN. Skin expression of mammalian target of rapamycin and forkhead box transcription factor O1, and serum insulin-like growth factor-1 in patients with acne vulgaris and their relationship with diet. Br J Dermatol. 2016;174(6):1299-307. https://doi.org/10.1111/ bjd.14409 PMid:26799159
Maddur MS, Miossec P, Kaveri SV, Bayry J. Th17 cells: Biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol. 2012;181(1):8-18. https:// doi.org/10.1016/j.ajpath.2012.03.044 PMid:22640807
Melnik BC, Zouboulis CC. Potential role of FoxO1 and mTORC1 in the pathogenesis of Western diet-induced acne. Exp Dermatol. 2013;22(5):311-5. https://doi.org/10.1111/exd.12142 PMid:23614736
Melnik B. Dietary intervention in acne: Attenuation of increased mTORC1 signaling promoted by Western diet. Dermatoendocrinol. 2012;4(1):20-32. https://doi.org/10.4161/ derm.19828 PMid:22870349
Melnik BC. Nutrient and growth factor signalling in acne sensed by FoxO1 and mTORC1. World Clin Dermatol. 2013;1(1):52-88. https://doi.org/10.5005/jp/books/11981_4
Melnik BC. Linking diet to acne metabolomics, inflammation, and comedogenesis: An update. Clin Cosmet Investig Dermatol. 2015;8:371-88. https://doi.org/10.2147/ccid.s69135 PMid:26203267
Monfrecola G, Lembo S, Caiazzo G, De Vita V, Di Caprio R, Balato A, et al. Mechanistic target of rapamycin (mTOR) expression is increased in acne patients’ skin. Exp Dermatol. 2016;25(2):153-5. https://doi.org/10.1111/exd.12885 PMid:26477999
Bongiovanni L, Müller EJ, Della Salda L. Survivin in skin pathologies. Exp Dermatol. 2011;20(6):457-63. https://doi. org/10.1111/j.1600-0625.2011.01273.x PMid:21585553
Assaf HA, Abdel-Maged WM, Elsadek BE, Hassan MH, Adly MA, Ali SA. Survivin as a novel biomarker in the pathogenesis of acne vulgaris and its correlation to insulin-like growth factor-I. Dis Markers. 2016;2016:7040312. https://doi. org/10.1155/2016/7040312 PMid:27803511
Bowen AR, Hanks AN, Murphy KJ, Florell SR, Grossman D. Proliferation, apoptosis, and survivin expression in keratinocytic neoplasms and hyperplasias. Am J Dermatopathol. 2004;26(3):177-81. https://doi. org/10.1097/00000372-200406000-00001 PMid:15166502
Agak GW, Qin M, Nobe J, Kim MH, Krutzik SR, Tristan GR, et al. Propionibacterium acnes induces an IL-17 response in acne vulgaris that is regulated by Vitamin A and Vitamin D. J Invest Dermatol. 2014;134(2):366-73. https://doi.org/10.1038/ jid.2013.334 PMid:23924903
Kelhälä HL, Palatsi R, Fyhrquist N, Lehtimäki S, Väyrynen JP, Kallioinen M, et al. IL-17/Th17 pathway is activated in acne lesions. PLoS One. 2014;9(8):e105238. https://doi.org/10.1371/ journal.pone.0105238 PMid:25153527
Moradi Tuchayi S, Makrantonaki E, Ganceviciene R, Dessinioti C, Feldman SR, Zouboulis CC. Acne vulgaris. Nat Rev Dis Primers. 2015;1:15029. https://doi.org/10.1038/ nrdp.2015.29 PMid:27189872
Thiboutot DM, Layton AM, Anne Eady E. IL-17: A key player in the P. Acnes inflammatory cascade? J Invest Dermatol. 2014;134(2):307-10. https://doi.org/10.1038/jid.2013.400 PMid:24424453
Shaheen B, Gonzales M. A microbial etiology: What is the evidence?. Br J Dermatol. 2011;165(3):474-85.
Sugisaki H, Yamanaka K, Kakeda M, Kitagawa H, Tanaka K, Watanabe K, et al. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: Host response but not bacterial species is the determinant factor of the disease. J Dermatol Sci. 2009;55(1):47-52. https://doi.org/10.1016/j. jdermsci.2009.02.015 PMid:19375895
Kubba R, Bajaj AK, Thappa DM, Sharma R, Vedamurthy M, Dhar S, et al. Acne in India: Guidelines for management - IAA consensus document. Indian J Dermatol Venereol Leprol. 2009;75 Suppl 1:1-62. PMid:19282578
Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol. 2003;121(1):20-7. https://doi. org/10.1046/j.1523-1747.2003.12321.x PMid:12839559
Kistowska M, Meier B, Proust T, Feldmeyer L, Cozzio A, Kuendig T, et al. Propionibacterium acnes promotes Th17 and Th17/Th1 responses in acne patients. J Invest Dermatol. 2015;135(1):110-8. https://doi.org/10.1038/jid.2014.290 PMid:25010142.
How to Cite
Copyright (c) 2020 Sri Yusfinah Masfah Hanum, Ellyza Nasrul, Nelva Karmila Jusuf, Eti Yerizel (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.